Ling-Yan Su | Molecular Neuroscience | Best Researcher Award

Posted on 30/06/2025 by Neuroscientists

Dr. Ling-Yan Su | Molecular Neuroscience | Best Researcher Award

Dr. Ling-Yan Su, Yunnan Agricultural University, China.

Professor Ling-Yan Su is a leading figure in the field of food science and plant physiology, currently serving at the College of Food Science and Technology, Yunnan Agricultural University. With a solid academic foundation from Yunnan University and the Chinese Academy of Sciences, she has built a dynamic career that bridges molecular biology and applied agricultural research. Her pioneering work on melatonin-based pre-harvest treatments has significantly advanced our understanding of natural preservation techniques, especially in prolonging the post-harvest life and quality of fruits like Myrica rubra. Her research focuses on enhancing antioxidant systems, inhibiting spoilage, and activating plant defense pathways through sustainable, low-toxicity treatments.

Profile

Google Scholar

🎓 Early Academic Pursuits

Ling-Yan Su’s journey in the biological sciences began with a Bachelor of Science degree from the School of Life Science at Yunnan University (2007–2011). Demonstrating academic curiosity and determination early on, she expanded her horizons through a year-long visiting student program (2010–2011) at the prestigious Kunming Institute of Zoology, affiliated with the Chinese Academy of Sciences. This experience laid the foundation for her doctoral research, which she pursued at the same institute from 2011 to 2017, where she rigorously explored complex biological systems, further solidifying her passion for food science and plant physiology.

🧪 Professional Endeavors in Science

Professor Su’s professional career has been marked by consistent growth across esteemed academic institutions. Following her Ph.D., she joined the Kunming Institute of Zoology as a research assistant, rapidly advancing to the role of associate professor. In 2022, she transitioned to the College of Food Science and Technology at Yunnan Agricultural University, initially as an associate professor before her promotion to full professor within the same year. Her academic trajectory reflects a blend of deep research engagement and an evolving role in shaping food science education and innovation in China.

🌿 Contributions and Research Focus

Professor Su’s groundbreaking work lies at the intersection of plant physiology, post-harvest fruit biology, and food preservation technology. She has made significant contributions to understanding how melatonin, a naturally occurring compound, can be leveraged to extend the post-harvest shelf life of Myrica rubra (Chinese bayberry). Her studies demonstrate that melatonin pre-harvest treatments reduce oxidative stress markers, inhibit microbial decay, and activate the phenylpropanoid pathway, resulting in elevated antioxidant activity. This line of research not only reveals novel mechanisms of fruit preservation but also opens sustainable avenues in post-harvest biology and food safety.

🏅 Accolades and Recognition

While formal awards are not listed, Professor Su’s rapid academic promotions and appointments at prestigious research institutes such as the Chinese Academy of Sciences and Yunnan Agricultural University underscore her recognition within the scientific community. Her work is contributing to a growing body of literature on sustainable food science innovations, earning her esteem among peers and collaborators in the agricultural biotechnology field.

🌱 Impact and Influence

Professor Su’s innovative application of melatonin in fruit preservation has substantial implications for food technology and agricultural practices. Her research directly addresses global concerns such as food spoilage, post-harvest losses, and chemical-free preservation methods. By enhancing natural antioxidant defenses and inhibiting spoilage at a molecular level, her work supports both farmers and consumers in accessing healthier and longer-lasting produce, especially within the context of environmentally conscious food systems.

🔬 Legacy in Food Science

The legacy Professor Su is building centers around translating scientific inquiry into practical solutions for real-world agricultural challenges. Her research is charting a course for future studies in the bio-preservation of fruits and vegetables using natural treatments. As she continues to mentor students and collaborate across disciplines, her influence is extending into the next generation of food scientists and researchers focused on plant biochemistry, post-harvest technology, and sustainable agricultural innovation.

🚀 Future Contributions and Vision

Looking ahead, Professor Ling-Yan Su is poised to further explore how endogenous compounds like melatonin can be applied across various fruits and food crops. Her vision includes broadening the scope of natural food preservation strategies and delving deeper into molecular pathways that regulate plant defense responses. As a respected academic and scientist, her future contributions are expected to shape healthier food systems and deepen scientific understanding of plant–microbe–compound interactions.

Publication

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)
Authors: DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, …
Year: 2021

Activation of PPARA-mediated autophagy reduces Alzheimer disease-like pathology and cognitive decline in a murine model
Authors: R Luo, LY Su, G Li, J Yang, Q Liu, LX Yang, DF Zhang, H Zhou, M Xu, …
Year: 2020

Melatonin attenuates MPTP-induced neurotoxicity via preventing CDK5-mediated autophagy and SNCA/α-synuclein aggregation
Authors: LY Su, H Li, L Lv, YM Feng, GD Li, R Luo, HJ Zhou, XG Lei, L Ma, JL Li, …
Year: 2015

Decreased mitochondrial DNA copy number in the hippocampus and peripheral blood during opiate addiction is mediated by autophagy and can be salvaged by melatonin
Authors: YM Feng, YF Jia, LY Su, D Wang, L Lv, L Xu, YG Yao
Year: 2013

Association of the LRRK2 genetic polymorphisms with leprosy in Han Chinese from Southwest China
Authors: D Wang, L Xu, L Lv, LY Su, Y Fan, DF Zhang, R Bi, D Yu, W Zhang, XA Li, …
Year: 2015

Atg5- and Atg7-dependent autophagy in dopaminergic neurons regulates cellular and behavioral responses to morphine
Authors: LY Su, R Luo, Q Liu, JR Su, LX Yang, YQ Ding, L Xu, YG Yao
Year: 2017

Positive selection rather than relaxation of functional constraint drives the evolution of vision during chicken domestication
Authors: MS Wang, R Zhang, LY Su, Y Li, MS Peng, HQ Liu, L Zeng, DM Irwin, …
Year: 2016

Melatonin alleviates morphine analgesic tolerance in mice by decreasing NLRP3 inflammasome activation
Authors: Q Liu, LY Su, C Sun, L Jiao, Y Miao, M Xu, R Luo, X Zuo, R Zhou, P Zheng, …
Year: 2020

Out of Southern East Asia of the brown rat revealed by large-scale genome sequencing
Authors: L Zeng, C Ming, Y Li, LY Su, YH Su, NO Otecko, A Dalecky, S Donnellan, …
Year: 2018

Moringa oleifera Lam. leaves as new raw food material: A review of its nutritional composition, functional properties, and comprehensive application
Authors: M Yang, L Tao, XR Kang, ZL Wang, LY Su, LF Li, F Gu, CC Zhao, J Sheng, …
Year: 2023

✅ Conclusion

Professor Su’s academic journey and research contributions exemplify scientific excellence rooted in sustainability and innovation. Her work not only provides practical solutions to post-harvest challenges but also contributes to broader efforts in reducing food waste and promoting natural preservation methods. As she continues to mentor young researchers and expand her studies, Professor Su is well-positioned to leave a lasting impact on food science and agricultural biotechnology. Her career reflects a thoughtful integration of research, application, and forward-looking vision in the quest for healthier and more resilient food systems.

Joice Margareth de Almeida Rodolpho | Molecular Neuroscience | Best Researcher Award

Posted on 14/06/2025 by Neuroscientists

Mrs. Joice Margareth de Almeida Rodolpho | Molecular Neuroscience | Best Researcher Award

Mrs. Joice Margareth de Almeida Rodolpho, Universidade Federal de São Carlos, Brazil.

Joice Margareth de Almeida Rodolpho is a dedicated Brazilian researcher with a strong foundation in biotechnology, parasitology, immunology, and molecular biology. She earned her Master’s and Ph.D. from the Federal University of São Carlos (UFSCar), where she explored the role of eosinophils as antigen-presenting cells in parasitic infections like Toxocara canis and Schistosoma mansoni. Her work is recognized for integrating experimental immunology with therapeutic innovations, such as the evaluation of natural plant extracts and nanomaterials for infection control. She further specialized in Flow Cytometry and Oncohematology, enhancing her analytical capabilities. With multiple awards and citations, her impactful contributions continue to strengthen Brazil’s standing in parasitological and immunological research.

Profile

Orcid

🎓 Early Academic Pursuits

Joice Margareth de Almeida Rodolpho began her academic journey in Brazil, developing a strong foundation in the life sciences. Her early interest in molecular biology and parasitology led her to pursue advanced studies at the esteemed Universidade Federal de São Carlos (UFSCar). She earned her Master’s degree in Biotechnology between 2009 and 2012, conducting significant research on Toxocara canis, particularly on the phenotypic characterization of eosinophils as antigen-presenting cells. This early work not only revealed her meticulous scientific inquiry but also laid the groundwork for her deeper exploration into immunology.

🧬 Professional Endeavors in Molecular and Evolutionary Genetics

Driven by a passion for understanding immune responses, Joice pursued a Ph.D. in Evolutionary Genetics and Molecular Biology at UFSCar from 2013 to 2017. Her doctoral research focused on the role of eosinophils as antigen-presenting cells both in vitro and ex vivo, offering vital insights into host-parasite interactions and immune regulation. Her work during this period was supported by a prestigious FAPESP scholarship, demonstrating her academic excellence and the relevance of her contributions. Under the mentorship of Professor Fernanda de Freitas Anibal, Joice refined her skills in experimental immunology and cellular biology.

🧪 Contributions and Research Focus in Parasitology and Immunopathology

Joice Rodolpho’s primary research interests lie at the intersection of parasitology, cellular immunology, and experimental pathology. Her studies explore how parasitic infections, such as those caused by Schistosoma mansoni and Toxocara canis, affect immune cell function, especially eosinophils. She has also contributed to investigations into natural plant extracts, like Mentha piperita L., assessing their therapeutic potential in modulating parasitic infections. Moreover, she extended her expertise to the field of nanomaterials, evaluating the cytotoxicity and cell death mechanisms induced by compounds like Ag₂WO₄, thus bridging classical parasitology with emerging biomedical technologies.

🏅 Accolades and Recognition in Scientific Circles

Throughout her career, Joice has received several recognitions that reflect the impact and originality of her research. In 2010, she was honored with a Menção Honrosa (Honorable Mention) for her work on Mentha piperita L. in treating Schistosoma mansoni, earning 2nd place in diagnostics and treatment. She continued to gain academic acclaim with awards at major conferences, including the VI Congresso da Sociedade Paulista de Parasitologia (2012) and the XXII B-MRS Meeting in 2024, highlighting her work on cytotoxic responses and innovative parasitological control methods. In 2024, her project on the parasitological and pathological evaluation of AW-HRL-C for schistosomiasis control was notably recognized by UNIFESP.

🧠 Impact and Influence in Experimental Immunology

Joice’s dedication to experimental immunology and cytometry has allowed her to mentor and influence upcoming researchers, especially in specialized fields such as flow cytometry. Her recent specialization in Immunology and Oncohematology by Flow Cytometry (2021–2022) at IPESSP further enriched her profile, showcasing her commitment to continuous learning and application of advanced technologies in immune profiling. Her ability to merge classical immunopathology with state-of-the-art cytometric tools reflects her versatility and forward-thinking scientific approach.

🌱 Legacy and Future Contributions in Biomedical Science

Poised to make lasting contributions, Joice Margareth de Almeida Rodolpho stands at the forefront of research into host-pathogen interactions, parasitic disease management, and immune cell function modulation. Her unique interdisciplinary approach—integrating molecular biology, natural product pharmacology, and immunological techniques—positions her as a valuable contributor to both academic research and potential therapeutic advancements. She is expected to lead innovative research in the treatment of neglected tropical diseases and immunological disorders, with implications for global health.

🔬 Research Field Relevance and Scientific Identity

As a scholar deeply embedded in the Brazilian scientific ecosystem, Joice’s identity is reflected in her multiple citation forms, indicating her widespread academic collaborations and international visibility. Her expertise bridges evolutionary genetics, biotechnology, cytometry, and immunoparasitology—making her a multifaceted researcher. Her contributions are cited under various names such as “RODOLPHO, JOICE M. A.” and “Joice Margareth de Almeida Rodolpho,” reflecting a robust presence in scholarly literature and ensuring her work continues to guide parasitological and immunological research for years to come.

Publication

Title: Biomarkers and Mental Disorders: A Relevance Analysis Using a Random Forest Algorithm
Authors: Joice M. A. Rodolpho; Krissia F. Godoy; Bruna D. L. Fragelli; Jaqueline Bianchi; et al.
Year: 2025

Title: Death Risk Score Model of Hospitalized COVID‐19 Patients: A Cohort Study
Authors: Gustavo A. Cruz; Thais B. Boteon; Henrique Pott; Joice M. A. Rodolpho; et al.
Year: 2025

Title: Synergistic Antifungal Effect and In Vivo Toxicity of a Monoterpene Isoespintanol Obtained from Oxandra xylopioides Diels
Authors: Orfa I. C. Martínez; Alberto Angulo; Joice Rodolpho; Krissia F. Godoy; et al.
Year: 2024

Title: Synergistic Antifungal Effect and In Vivo Toxicity of the Monoterpene Isoespintanol Obtained from Oxandra xylopioides Diels (Preprint)
Authors: Orfa I. C. Martínez; Alberto Angulo; Joice M. A. Rodolpho; et al.
Year: 2024

Title: Carbon Black CB-EDA Nanoparticles in Macrophages: Changes in the Oxidative Stress Pathway and in Apoptosis Signaling
Authors: Joice M. A. Rodolpho; Krissia F. Godoy; Bruna D. L. Fragelli; et al.
Year: 2023

Title: HGPRT and PNP: Recombinant Enzymes from Schistosoma mansoni and Their Role in Immunotherapy during Experimental Murine Schistosomiasis
Authors: Bruna D. L. Fragelli; Ana C. Fattori; Joice M. A. Rodolpho; et al.
Year: 2023

Title: Titanium Dioxide Nanoparticle (TiO2 NP) Induces Toxic Effects on LA-9 Mouse Fibroblast Cell Line
Authors: Ana C. M. Fattori; Patricia Brassolatti; Joice M. A. Rodolpho; et al.
Year: 2023

Title: Analysis of Cytotoxicity and Genotoxicity in a Short-Term Dependent Manner Induced by a New Titanium Dioxide Nanoparticle in Murine Fibroblast Cells
Authors: Pedrino, M.; Brassolatti, P.; Joice M. A. Rodolpho; et al.
Year: 2022

Title: Functionalized Titanium Nanoparticles Induce Oxidative Stress and Cell Death in Human Skin Cells
Authors: Brassolatti, P.; Joice M. A. Rodolpho; Krissia F. Godoy; et al.
Year: 2022

Title: Toxicological Effects of the Mixed Iron Oxide Nanoparticle (Fe₃O₄ NP) on Murine Fibroblasts LA-9
Authors: Alves Feitosa, K.; Joice M. A. Rodolpho; et al.
Year: 2022

🧾 Conclusion

Joice Rodolpho’s academic journey and scientific contributions reveal a researcher of high caliber, committed to advancing our understanding of host-pathogen dynamics and immune system function. Her work, grounded in rigorous experimentation and innovation, holds promise for developing novel therapies for neglected tropical diseases. With a forward-looking approach and interdisciplinary expertise, she stands out as a key contributor in biomedical science, poised to influence future discoveries in immunopathology and disease control.

Ivan Zivotic | Molecular Neuroscience | Best Researcher Award

Posted on 14/06/2025 by Neuroscientists

Dr. Ivan Zivotic | Molecular Neuroscience | Best Researcher Award

Dr. Ivan Zivotic, Vinča Institute of Nuclear Sciences, University of Belgrade, Serbia.

Dr. Ivan Životić is a Serbian molecular geneticist whose research focuses on the genetic epidemiology of complex human diseases such as atherosclerosis, congenital kidney anomalies, and chronic inflammatory conditions. With a Ph.D. in Molecular Biology from the University of Belgrade and a master’s background in applied genetics, he has cultivated a strong academic and research foundation. Currently affiliated with the “Vinča” Institute of Nuclear Sciences, he has authored 16 scientific papers and coauthored over 40 abstracts, contributing meaningfully to the fields of genomics and transcriptomics. His expertise lies in deciphering gene-disease associations using modern molecular and computational tools.

Profile

Orcid

🎓 Early Academic Pursuits

Born on July 23, 1986, in Belgrade, Serbia, Dr. Ivan Životić embarked on a promising academic journey rooted in the life sciences. His passion for unraveling the genetic underpinnings of human diseases led him to the Faculty of Biology at the University of Belgrade. He obtained a Master’s degree in Molecular Biology and Physiology in 2011, specializing in applied genetics within the Department of Population Genetics. His master’s thesis explored the role of GST M1 and GST T1 gene deletion polymorphisms in multiple sclerosis, laying the groundwork for his deep engagement in genetic epidemiology. He continued with doctoral studies at the same faculty, where he focused on the molecular biology of eukaryotes. His Ph.D. thesis examined the association between genetic variants on chromosome 9p21 and transcription levels of CDKN2B and HACD4 genes with atherosclerosis and its complications, graduating with an impressive average grade of 9.7.

🧬 Research Focus in Molecular Genetics

Dr. Životić’s research is rooted in molecular genetics with a core focus on the genetic epidemiology of complex human diseases. His scientific curiosity revolves around how genomic and transcriptomic profiles contribute to the development of conditions such as atherosclerosis, congenital kidney anomalies, and chronic inflammatory diseases. His work integrates molecular tools and population studies to understand genetic variants and their influence on disease onset, making valuable contributions to the broader fields of genomics and transcriptomics. His dedication to uncovering genetic risk factors reflects a commitment to improving predictive medicine and tailored healthcare strategies.

🏥 Professional Endeavors in Medical Sciences

Professionally, Dr. Životić holds a distinguished position at the “Vinča” Institute of Nuclear Sciences, a leading Serbian national research institute affiliated with the University of Belgrade. His role within this multidisciplinary environment places him at the forefront of translational research, bridging the gap between laboratory discoveries and clinical applications. Collaborating with esteemed researchers and clinicians, he continually advances the understanding of how molecular mechanisms translate into disease phenotypes, particularly within the realm of cardiovascular and renal health.

📚 Contributions to Scientific Literature

Dr. Životić has authored 16 research papers in internationally recognized SCI journals and coauthored over 40 scientific abstracts presented at prestigious conferences. These publications represent his steady and thoughtful contributions to the academic community. His scholarly output reflects not only the depth of his investigations but also his role in team-based science. His Scopus-indexed h-index of 4 and 54 heterocitations (as of February 12, 2025) demonstrate a growing influence in the field of molecular medical research.

🏆 Accolades and Academic Recognition

Dr. Životić’s academic achievements are complemented by consistent scholarly excellence. With high average grades throughout his university education and a commendable Ph.D. thesis addressing significant clinical concerns, he has earned recognition within his academic circles. His scientific insights into cardiovascular genomics have positioned him as a promising voice among early-career researchers in Serbia’s biomedical community. His educational accomplishments, including supervision under renowned expert Dr. Maja Živković, reflect a foundation built on rigor and mentorship.

🌍 Scientific Impact and Global Relevance

The research conducted by Dr. Životić holds substantial relevance not only within Serbia but also internationally, given the global burden of atherosclerosis and other complex diseases. His work on gene expression, chromosomal variations, and their clinical correlations contributes to a better understanding of disease mechanisms that affect millions worldwide. His interdisciplinary approach, blending genetics, epidemiology, and bioinformatics, is increasingly critical for the development of precision medicine.

🔬 Legacy and Future Contributions

Looking forward, Dr. Životić is poised to make further breakthroughs in the fields of medical genomics and complex disease genetics. As the need for personalized medicine grows, his contributions are expected to inform diagnostic and therapeutic approaches that are tailored to individual genetic backgrounds. With a strong foundation, a collaborative research spirit, and an unwavering focus on human health, Dr. Životić is building a scientific legacy that will inspire future generations of geneticists and medical researchers.

Publication

Title: Expression of HMGB1, TGF-β1, BIRC3, ADAM17, CDKN1A, and FTO in Relation to Left Ventricular Remodeling in Patients Six Months after the First Myocardial Infarction: A Prospective Study
Authors: Jovana Kuveljic, Ana Djordjevic, Ivan Zivotic, Milica Dekleva, Ana Kolakovic, Maja Zivkovic, Aleksandra Stankovic, Tamara Djuric
Year: 2024

Title: Gene expression of chemokines CX3CL1 and CXCL16 and their receptors, CX3CR1 and CXCR6, in peripheral blood mononuclear cells of patients with relapsing-remitting multiple sclerosis – a pilot study
Authors: Ljiljana Stojkovic, Aleksandra Stankovic, Ivan Zivotic, Evica Dincic, Dragan Alavantic, Maja Zivkovic
Year: 2020

Title: The Effects of Aronia melanocarpa Juice Consumption on the mRNA Expression Profile in Peripheral Blood Mononuclear Cells in Subjects at Cardiovascular Risk
Authors: Ljiljana Stojković, Ivan Jovanovic, Manja Zec, Ivan Zivotic, Ivan Zivotić, Jovana Kuveljić, Ana Kolaković, Ivana Kolić, Ana Djordjević, Marija Glibetić et al.
Year: 2020

Title: CDKN2B gene expression is affected by 9p21.3 rs10757278 in CAD patients, six months after the MI
Authors: Zivotić I, Djurić T, Stanković A, Milasinovic D, Stankovic G, Dekleva M, Marković Nikolić N, Alavantić D, Zivković M
Year: 2019

Title: The HACD4 haplotype as a risk factor for atherosclerosis in males
Authors: Zivotić I, Djurić T, Stanković A, Ivančević I, Končar I, Milasinovic D, Stankovic G, Alavantić D, Zivković M
Year: 2018

Title: 9p21 locus rs10757278 is associated with advanced carotid atherosclerosis in a gender-specific manner
Authors: Zivotić I, Djurić T, Stanković A, Djordjević A, Končar I, Davidović L, Alavantić D, Zivković M
Year: 2016

Title: Genetic Variants in the Vicinity of LGALS-3 Gene and LGALS-3 mRNA Expression in Advanced Carotid Atherosclerosis: An Exploratory Study
Authors: Djordjevic A, Zivkovic M, Stankovic A, Zivotic I, Koncar I, Davidovic L, Alavantic D, Djuric T
Year: 2016

Title: The glutathione S-transferase T1 deletion is associated with susceptibility to multiple sclerosis
Authors: Živković M, Životić I, Dinčić E, Stojković L, Vojinović S, Stanković A
Year: 2013

✅ Conclusion

Dr. Životić exemplifies a new generation of biomedical scientists committed to bridging genetic science with clinical application. His work not only enhances the understanding of disease pathogenesis but also supports the advancement of personalized medicine. With a growing academic presence, a commitment to collaborative research, and a focus on translational impact, Dr. Životić is well-positioned to make lasting contributions to the global scientific community.

Rosario Osta | Molecular and Cellular Neuroscience | Best Researcher Award

Posted on 11/06/202511/06/2025 by Neuroscientists

Prof.Dr. Rosario Osta | Molecular and Cellular Neuroscience | Best Researcher Award

Prof. Dr. Rosario Osta, CIBERNED-Fundación Instituto de Investigación Sanitaria de Aragón-Universidad de Zaragoza, Spain.

Prof. Rosario Osta Pinzolas is a distinguished geneticist and full professor at the University of Zaragoza, Spain. Her academic roots in veterinary sciences and a Ph.D. in Genetics laid the foundation for a prolific career in biomedical research, particularly in the fields of neuroscience and genetic disorders. With leadership roles in multiple high-profile research consortia such as CIBERNED, TRICALS, and ENCALS, she has established herself as a central figure in neurodegenerative disease research. Her scholarly output includes over 100 indexed publications, multiple national and international research projects, and an h-index exceeding 45.

Profile

Orcid

Scopus

🎓 Early Academic Pursuits

Rosario Osta Pinzolas began her academic journey with a solid foundation in veterinary sciences, graduating as Licenciada en Veterinaria from the University of Zaragoza in 1989. Her academic inclinations quickly shifted toward molecular genetics, leading her to complete a Ph.D. in Genetics at the same university in 1994. Her early studies were driven by a deep curiosity about the mechanisms of heredity and gene expression, setting the tone for a lifelong commitment to biomedical research. These formative years cultivated her scientific rigor and sowed the seeds for a career that would eventually bridge basic science and translational medicine.

🧬 Professional Endeavors in Genetics and Biomedicine

Prof. Osta currently holds the esteemed title of Catedrática (Full Professor) in the Department of Anatomy, Embryology, and Genetics at the Faculty of Veterinary Medicine, University of Zaragoza. Since 2018, she has led her department with a focus on integrative biomedical sciences. She is the principal investigator of the LAGENBIO group recognized by both the Aragon Health Research Institute and the Government of Aragon. Under her leadership, the group has developed two major subprograms: TERAGEN and REGENERAGEN. As coordinator of the “Neuroscience and Mental Health Program” at IISA, she has spearheaded numerous efforts to understand and address neurological diseases through genetic approaches.

🧠 Contributions and Research Focus in Neuroscience

A prominent figure in neuroscience, Prof. Osta’s research lies at the intersection of genetics and neurodegeneration. She is currently the principal investigator of the only Aragon-based group within CIBERNED (Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas), reflecting her national influence. Her team represents Zaragoza in prominent European consortia such as TRICALS and ENCALS, both focused on amyotrophic lateral sclerosis (ALS) and other motor neuron diseases. Through more than 100 indexed publications, predominantly in top-tier journals, her work delves into the molecular underpinnings of neurological disorders and explores regenerative medicine strategies, thereby contributing to innovative therapeutic avenues.

🧪 Accolades and Recognition in Scientific Excellence

Prof. Osta’s academic and research career has been punctuated by consistent recognition. She has completed five research productivity periods and one technology transfer period, acknowledged by CNEAI — a mark of sustained scientific impact. She has led over 74 research projects and contributed to more than 100 collaboration contracts, earning her four competitive research awards from respected institutions including CORIS, AREA, IIS, and SEBBM. Her contributions have been lauded not only for scientific quality but also for practical relevance in biomedical advancements.

🚀 Innovation and Impact in Translational Research

An ardent advocate for science with societal impact, Prof. Osta has significantly contributed to technology transfer. She holds nine patents, five of which have been licensed to industry partners. Her collaborations with companies have led to meaningful translational outputs, emphasizing her role in bridging the gap between academic research and real-world solutions. As former Director of the Technology Transfer and Innovation Secretariat at the University of Zaragoza for nearly a decade, she played a crucial role in institutional innovation strategies. Her involvement in joint university-company chairs and her role in the UZ Technology-Based Business Creation Committee for over 12 years further underscore her influence on academic entrepreneurship.

📚 Mentorship and Educational Leadership

Beyond the lab, Prof. Osta has left a profound mark as an educator and mentor. Since 2013, she has coordinated the Interuniversity Doctoral Program in Biomedical and Biotechnological Sciences, a joint initiative between the Universities of Zaragoza and La Rioja. Her mentorship includes the supervision of 13 Ph.D. theses — 9 of which earned international distinction and 6 received extraordinary doctoral awards. Her influence extends to guiding numerous undergraduate and master’s theses, fostering a new generation of scientists with a deep commitment to research excellence and innovation.

🌍 Legacy and Future Contributions

Prof. Rosario Osta’s legacy is defined by her ability to integrate scientific discovery, mentorship, and innovation. As a member of the Scientific Committee of the Luzón Foundation, her vision reaches beyond academia into public health advocacy and strategic research planning. With nearly 19,000 citations on Google Scholar and an h-index of 45, her work continues to inspire and inform global research communities. Her continued leadership in collaborative European projects ensures her contributions will shape the future of neuroscience, genetics, and translational medicine for years to come.

Publication

Title: Novel FKBP prolyl isomerase 1A (FKBP12) ligand promotes functional improvement in SOD1G93A amyotrophic lateral sclerosis (ALS) mice
Authors: L. Moreno-Martinez, N. Gaja-Capdevila, L. Mosqueira-Martín, R. Osta, F.J. Gil-Bea
Year: 2025

Title: Identifying Hub Genes and miRNAs Associated with Alzheimer’s Disease: A Bioinformatics Pathway to Novel Therapeutic Strategies
Authors: E. Gascón, A.C. Calvo, N. Molina, P. Zaragoza, R. Osta
Year: 2024

Title: Comparative Blood Profiling Based on ATR-FTIR Spectroscopy and Chemometrics for Differential Diagnosis of Patients with Amyotrophic Lateral Sclerosis—Pilot Study
Authors: K. Tkachenko, J.M. González Sáiz, A.C. Calvo, R. Osta, C. Pizarro Millán
Year: 2024

Title: Sex differences on constitutive long non-coding RNA expression: Modulatory effect of estradiol and testosterone in muscle cells
Authors: T. López-Royo, L. Moreno-Martinez, L. Moreno-García, R. Manzano, R. Osta
Year: 2024

Title: Differentially expressed lncRNAs in SOD1 G93A mice skeletal muscle: H19, Myhas and Neat1 as potential biomarkers in amyotrophic lateral sclerosis
Authors: T. López-Royo, L. Moreno-Martinez, P. Zaragoza, R. Manzano, R. Osta
Year: 2024

Title: Proteomic profiling of human plasma extracellular vesicles identifies PF4 and C1R as novel biomarker in sarcopenia
Authors: P. Aparicio, D. Navarrete-Villanueva, A. Gómez-Cabello, R. Osta, R. Manzano
Year: 2024

Title: Sporadic Amyotrophic Lateral Sclerosis Skeletal Muscle Transcriptome Analysis: A Comprehensive Examination of Differentially Expressed Genes
Authors: E. Gascón, P. Zaragoza, A.C. Calvo, R. Osta
Year: 2024

Title: Intermediate Repeat Expansion in the ATXN2 Gene as a Risk Factor in the ALS and FTD Spanish Population
Authors: D. Borrego-Hernández, J.F. Vázquez-Costa, R. Domínguez Rubio, M. Povedano, A. García-Redondo
Year: 2024

Title: New Insights into Endogenous Retrovirus-K Transcripts in Amyotrophic Lateral Sclerosis
Authors: L. Moreno-Martinez, S. Macías-Redondo, M.H.P. Strunk, R. Osta, J. Schoorlemmer
Year: 2024

Title: Analysis of Plasma-Derived Exosomal MicroRNAs as Potential Biomarkers for Canine Idiopathic Epilepsy
Authors: M. García-Gracia, L. Moreno-Martinez, A. Hernaiz, S. García-Belenguer, I. Martín-Burriel
Year: 2024

🏆 Conclusion

Based on her outstanding research contributions, innovation in translational science, mentorship record, and leadership within national and European research programs, Prof. Rosario Osta Pinzolas is an exceptionally strong candidate for the Best Researcher Award. Her profile reflects not only academic excellence but also societal impact and visionary leadership. While there is room for enhanced global outreach, her sustained achievements and contributions make her highly deserving of this prestigious recognition.

Aggrey Osogo | Molecular and Cellular Neuroscience | Best Research Article Award

Posted on 09/06/2025 by Neuroscientists

Mr. Aggrey Osogo | Molecular and Cellular Neuroscience | Best Research Article Award

Mr. AGGREY OSOGO, KIBABII UNIVERSITY, Kenya.

Aggrey Keya Osogo is a Kenyan plant virologist and Principal Technologist with a robust academic and professional background in plant pathology and crop protection. Beginning his academic journey in Vihiga County, he progressively advanced through diploma, higher diploma, and bachelor’s programs before earning a Master of Science in Crop Protection from MMUST. He is currently finalizing his Ph.D. research focused on the molecular characterization of common bean viruses using advanced ‘omics’ technologies.

Profile

Google Scholar

🎓 Early Academic Pursuits

Aggrey Keya Osogo began his academic journey with a strong foundational education in Vihiga County, Kenya. He completed his primary education at Kaptik Primary School (1978–1985) before proceeding to Mbale High School, where he obtained a Kenya Certificate of Secondary Education (KCSE) in 1989 with a commendable C+ grade. Driven by a passion for biology and plants, he pursued further studies in applied sciences, completing a Diploma in Applied Biology at Kenya Polytechnic in 1993 and later enhancing his credentials with a Higher Diploma in Applied Biology at Eldoret Polytechnic in 2002. His early academic journey laid a firm groundwork for his future specialization in plant pathology and virology.

🧪 Professional Endeavors

Mr. Osogo’s professional path is marked by consistent growth and commitment to laboratory sciences and academic instruction. Starting his career as a Laboratory Technologist in the Botany Department of Moi University in 1997, he gained vital hands-on experience in biological sciences. Over the years, he advanced to roles of increased responsibility, serving as a Senior Laboratory Technologist at Egerton University and later at MMUST. Since 2015, he has held the position of Chief Technologist at Kibabii University, where he also serves as a part-time lecturer. His teaching portfolio spans a range of botany-focused courses including plant taxonomy, microbiology, plant pathology, and botanical techniques, showcasing his expertise and devotion to nurturing future scientists.

🧬 Contributions and Research Focus

A dedicated researcher in plant pathology, Mr. Osogo’s scientific focus lies in virology, with significant work on crop protection and virus identification in staple crops. He holds a Master of Science in Crop Protection from Masinde Muliro University of Science and Technology (MMUST), where he researched the occurrence, distribution, and virulence of cassava brown streak viruses. Currently pursuing a Ph.D. at MMUST, his thesis emphasizes the molecular characterization of common bean viruses using cutting-edge ‘omics’ and high-throughput technologies. His research is crucial for developing disease-resistant crop varieties and ensuring food security for smallholder farmers in Western Kenya.

🏆 Accolades and Recognition

Although modest in public acclaim, Mr. Osogo’s career reflects quiet excellence and dedication to academic and research excellence. His steady rise from a laboratory technologist to a chief technologist and respected lecturer in Kenyan universities is a testament to his competence, perseverance, and deep-rooted passion for plant virology. His teaching engagements at both MMUST and Kibabii University have earned him respect among colleagues and students alike, establishing him as a role model in laboratory and field-based scientific instruction.

🌍 Impact and Influence

Through his extensive work in teaching, mentoring, and virological research, Mr. Osogo has had a lasting impact on Kenya’s academic and agricultural landscape. By identifying and understanding viral threats in major crops such as cassava and beans, he contributes directly to sustainable agriculture and improved yields for smallholder farmers. His influence extends beyond the classroom, as his research plays a crucial role in guiding disease management policies and enhancing diagnostic capacities in the region.

🌱 Legacy and Future Contributions

Looking ahead, Mr. Osogo aspires to become a lead scientist in plant virology, a goal well within reach given his ongoing contributions and academic progression. His legacy will be one of mentorship, scientific rigor, and a tireless quest to protect crops from viral diseases. As he nears completion of his Ph.D., he is positioned to take on greater roles in regional and international research collaborations, policy formulation, and capacity building in crop protection science.

🔬 Passion for Plant Science

Outside his formal roles, Mr. Osogo maintains a personal passion for botanizing, reflecting a deep, intrinsic love for plant life and exploration. This hobby not only complements his profession but also fuels his innovative thinking and observational skills in research. His ability to blend curiosity with scientific methodology makes him a standout figure in Kenya’s plant pathology field.

Publication

Title: Biodegradation of carbofuran in soils within Nzoia River Basin, Kenya
Authors: DO Onunga, IO Kowino, AN Ngigi, A Osogo, F Orata, ZM Getenga, …
Year: 2015

Title: Antimicrobial Coumarins from the Oyster Culinary-Medicinal Mushroom, Pleurotus ostreatus (Agaricomycetes), from Kenya
Authors: et al. Lilechi
Year: 2016

Title: Occurrence and distribution of begomoviruses infecting cassava in Western Kenya
Authors: MN Were, B Mukoye, AK Osogo, BC Mangeni, PAA Nyamwamu, …
Year: 2016

Title: Occurrence and distribution of cassava brown streak viruses in Western Kenya
Authors: AK Osogo, J Muoma, P Nyamwamu, CN Omuse, HK Were
Year: 2014

Title: Mapping of angular leaf spot disease hotspot areas in western Kenya towards its management
Authors: RK Leitich, W Arinaitwe, B Mukoye, DO Omayio, AK Osogo, HK Were, …
Year: 2016

Title: Distribution and biological characterization of potato virus y in Kenya
Authors: N Paul, M Benard, A Osogo
Year: 2014

Title: Occurrence, distribution, incidence, and severity of common bean viral diseases in resource-limited smallholder farms of western Kenya
Authors: AK Osogo, F Muyekho, P Okoth, H Were, G Ayaaga
Year: 2025

Title: Deciphering common bean (Phaseolus Vulgaris L.) microbiome assemblages reveal mechanistic insights into host-pathogen-microbiome interactions
Authors: AK Osogo, F Muyekho, H Were, P Okoth
Year: 2025

Title: Comprehensive metabolomic profiling of common bean (Phaseolus vulgaris L.) reveals biomarkers involved in viral disease detection and monitoring
Authors: AK Osogo, C Wekesa, FN Muyekho, HK Were, P Okoth
Year: 2025

Title: Genome-Wide Metatranscriptomics Crosswalk of Diseased Common Beans (Phaseolus vulgaris L) Unravels Critical Metabolic Pathways Involved in Plant Defense Mechanisms
Authors: AK Osogo, BS Sarkar, FN Muyekho, HK Were, P Okoth
Year: 2025

🏁 Conclusion

Aggrey Keya Osogo’s career is a testament to his unwavering dedication to plant virology and academic excellence. His progression from technologist to researcher and educator reflects both deep scientific commitment and impactful service to the agricultural sector. With a strong foundation, impactful research, and ongoing doctoral work, he is well-poised to become a leading voice in plant pathology not only in Kenya but across the region. His contributions are pivotal in strengthening food security and inspiring the next generation of plant scientists.

Lijuan Song | Cellular Neuroscience | Best Researcher Award

Posted on 26/04/2025 by Neuroscientists

Prof. Lijuan Song | Cellular Neuroscience | Best Researcher Award

Prof. Lijuan Song, Shanxi University of Chinese Medicine, China.

Throughout my career, I have passionately committed myself to integrating traditional Chinese medicine and Western medicine to advance the prevention and treatment of brain diseases, particularly ischemic cerebrovascular diseases and neurodegenerative disorders. By leading 14 national and provincial-level research projects, publishing over 130 academic papers, and contributing significantly to educational reform, I have built a strong foundation of scientific innovation and clinical excellence. With achievements recognized both nationally and internationally, and a consistent focus on combining research, teaching, and clinical work, I have significantly impacted the fields of neuroprotection and integrative medicine.

Profile

Scopus

🎓 Early Academic Pursuits

From the outset of my academic journey, I committed myself to the profound study of both traditional Chinese medicine and Western medicine, aspiring to bridge these two disciplines for the betterment of brain disease treatment. I pursued a rigorous path of education and research, laying a strong foundation that later allowed me to integrate diverse medical perspectives. Early in my career, I developed a particular interest in ischemic cerebrovascular diseases and neurodegenerative conditions, setting the stage for my lifelong mission to innovate in these critical areas.

🩺 Professional Endeavors

My professional career has been a dynamic blend of teaching, clinical practice, and scientific research, with a special focus on the prevention and treatment of brain diseases. I have successfully presided over 14 prestigious national and provincial-level projects, including those funded by the National Natural Science Foundation of China and the China Postdoctoral Science Foundation. Through my work, I have consistently emphasized the value of integrating traditional Chinese medicine with modern Western practices, ensuring that my clinical and research contributions are both culturally rooted and globally relevant.

🔬 Contributions and Research Focus

Throughout my research journey, I have concentrated on ischemic cerebrovascular diseases and neurodegenerative diseases, pioneering integrated approaches for their prevention and treatment. I have published 133 scientific papers, including 45 in SCI-indexed journals, with nearly 700 citations and an H-index of 15. One of my papers published in Neural Regeneration Research (NRR) has been recognized in the ESI highest citation list, achieving an impressive 97 citations. Beyond scientific research, I have also contributed significantly to educational innovation, authoring educational reform articles in the China Journal of Traditional Chinese Medicine and editing influential academic books.

🏆 Accolades and Recognition

My dedication to scientific advancement and education has earned me multiple prestigious honors. As the first author, I received the First Prize of the Academic Achievement Award from the China Association for the Promotion of Traditional Chinese Medicine Research. I have secured three authorized patents and two software copyrights, further showcasing my commitment to innovation. Additionally, my work has been featured through oral presentations at internationally renowned academic forums such as the Autoimmunity Congress and the World Stroke Congress, and recognized by respected platforms like Logic Neuroscience and Neuroweekly.

🌍 Impact and Influence

My influence extends beyond academia into public science education and medical philosophy dialogues. I have been repeatedly invited to deliver popular science talks and academic lectures at events like the Medical Philosophy Expert Meeting Room. My presentation at the 2022 International Neural Regeneration Summit Forum earned the Most Popular Award, affirming my ability to translate complex research into impactful and accessible knowledge for diverse audiences.

📚 Legacy in Education and Publishing

In addition to research and clinical achievements, I have made significant contributions to academic publishing and educational reform. My independently authored book, Progress in Integrated Traditional Chinese and Western Medicine Prevention and Treatment of Ischemic Cerebrovascular Disease, was published by People’s Health Publishing House. I have served as the first editor-in-chief for three important books, including Exploration of Teaching Models in Higher Education Pharmaceutical Education, which was honored by its selection into the “Library of Young Scholars in Universities,” marking a lasting contribution to the future of pharmaceutical education.

🚀 Future Contributions and Aspirations

Looking ahead, I aspire to further deepen the integration of traditional Chinese and Western medicine, particularly in brain disease prevention and therapy. I am committed to leading new research directions, fostering international collaborations, and nurturing a new generation of scholars who value the richness of cross-cultural medical practices. My future endeavors will continue to reflect a relentless pursuit of scientific excellence, compassionate clinical practice, and transformative education for the global health community.

Publication

Title: Effect of tetramethylpyrazine on neuroinflammation after cerebral ischemia and hypoxia based on mannose-binding lectin
Authors: Y. Duan, Yanzhe; J. Hua, Jianlin; Y. Yan, Yuqing; L. Song, Lijuan
Year: 2025

Title: Polysaccharides from Ganoderma lucidum attenuate cognitive impairment in 5xFAD mice by inhibiting oxidative stress and modulating mitochondrial dynamics via the Nrf2/antioxidative axis activation
Authors: J. Yu, Jiezhong; C. Ma, Cungen
Year: 2025

Title: Hydroxysafflower yellow A alleviates the inflammatory response in astrocytes following cerebral ischemia by inhibiting the LCN2/STAT3 feedback loop
Authors: L. Song, Lijuan; Y. Wu, Yige; L. Yin, Lijun; B. Xiao, Baoguo; C. Ma, Cungen
Year: 2025

Title: Mechanism of senegenin in improving lipopolysacchride-induced inflammatory response of BV2 microglial cell
Authors: B. Mu, Bingtao; M. Guo, Minfang; J. Yu, Jingwen; J. Yu, Jiezhong; L. Song, Lijuan
Year: 2025

Title: Effectiveness and Safety of Blending Traditional Chinese Medicine With Western Medicine for Enhanced Secondary Stroke Prevention: A Meta-analysis of RCTs
Authors: C. Wen, Chunli; L. Song, Lijuan; C. Ma, Cungen; F. Hu, Fengyun; L. Zhu, Linggqun
Year: 2025

🎯 Conclusion

Driven by a deep belief in the power of integration between ancient wisdom and modern science, I have continuously sought to pioneer new frontiers in brain disease treatment. My work has not only advanced research but also nurtured future generations through educational contributions and public science communication. Moving forward, I remain committed to expanding the reach and depth of integrated medicine, aiming to create a lasting legacy of innovation, healing, and academic excellence for global healthcare advancement.

Peng Jun | Cellular Neuroscience | Best Researcher Award

Posted on 22/04/2025 by Neuroscientists

Prof. Peng Jun | Cellular Neuroscience | Best Researcher Award

Prof. Peng Jun, Qilu hospital of Shandong University, China.

Professor Jun Peng is a distinguished leader in hematology, currently serving as Vice President of Qilu Hospital of Shandong University and Director of the Department of Hematology. His research is deeply rooted in the immunological pathogenesis and immune tolerance of primary immune thrombocytopenia (ITP), where he has made significant breakthroughs, including the publication of 14 papers in Blood. With a career supported by prestigious national awards, and leadership in 15 high-level research projects, Professor Peng is also a vital figure in Chinese hematology societies and editorial boards of leading journals. His academic rigor, clinical insight, and mentorship continue to shape the future of hematological science in China and beyond.

Profile

Scopus

🎓 Early Academic Pursuits

Professor Jun Peng embarked on his academic journey with a strong commitment to medicine and hematological sciences. From the outset, he exhibited exceptional academic talent and dedication, leading him to pursue both an M.D. and Ph.D. His early education laid a robust foundation for his future specialization in hematology, particularly in the complex field of immunological disorders. His doctoral work, recognized nationally, foreshadowed the groundbreaking contributions he would later make in immune thrombocytopenia research.

🩺 Professional Endeavors

Currently serving as the Vice President of Qilu Hospital of Shandong University, Professor Peng also holds the roles of Chief Physician, Professor, and Ph.D./M.D. Advisor, in addition to being the Director of the Department of Hematology. His clinical and academic responsibilities are carried out with unwavering diligence, mentoring future medical experts while overseeing high-level clinical operations. As a Distinguished Professor of Shandong University, he is actively engaged in shaping the university’s medical excellence on both national and global stages.

🔬 Contributions and Research Focus

At the heart of Professor Peng’s career is his pioneering work on the immunological pathogenesis and immune tolerance of primary immune thrombocytopenia (ITP). He has made substantial contributions to understanding the autoimmune mechanisms that underlie ITP, one of the most challenging hematologic disorders. His scholarly dedication is evidenced by the publication of 14 papers in Blood, a leading journal in hematology, where he served as corresponding or co-corresponding author. His research, grounded in clinical insight and scientific precision, has contributed new perspectives on immune regulation in hematologic diseases.

🏆 Accolades and Recognition

Professor Peng’s excellence has been recognized with numerous prestigious awards. These include the National Science Fund for Distinguished Young Scholars, which highlights his scientific creativity and impact at a young age. He is also a recipient of the One-Hundred National Outstanding Doctoral Dissertation Award, a testament to the academic rigor of his early research. Additionally, he earned the First Prize of the Natural Science Award for Outstanding Achievements in Scientific Research from the Ministry of Education and the Science and Technology Progress Award, reflecting both his academic brilliance and practical impact in the medical field.

🧪 Impact and Influence

Beyond research publications, Professor Peng has significantly influenced the broader scientific and medical communities. As a principal investigator, he has led fifteen national and ministerial-level research projects, including those funded by the National Natural Science Foundation of China and the 973 Program under the Ministry of Science and Technology. His leadership extends to active roles in national academic societies, including the Thrombosis and Hemostasis Group of the Chinese Society of Hematology and the Professional Committee of Experimental Hematology of the Chinese Society of Pathophysiology. These positions allow him to shape the direction of hematological research and clinical guidelines in China.

📚 Academic Leadership and Editorial Roles

A passionate advocate for knowledge dissemination, Professor Peng is a key editorial board member for several respected journals such as Thrombosis Journal, Thrombosis Research, Journal of Clinical Hematology, and the Chinese Journal of Hematology. Through these roles, he ensures that cutting-edge research in hematology is critically evaluated and shared widely, fostering a culture of scientific excellence and collaboration across the globe.

🌟 Legacy and Future Contributions

Professor Jun Peng’s legacy is being forged not only through his past achievements but also through his continued commitment to the advancement of hematological science. His influence spans clinical innovation, academic mentorship, and scientific discovery. As he continues to push the boundaries of understanding in ITP and immune tolerance, he inspires a new generation of physician-scientists. The impact of his work promises to resonate for years to come, offering hope and healing for patients and propelling China’s medical research onto the world stage.

Publication

Title: Autoimmune effector mechanisms associated with a defective immunosuppressive axis in immune thrombocytopenia (ITP)
Authors: Qizhao Li, Geneviève Marcoux, Yuefen Hu, Jung Peng, John W. Semple
Year: 2024

Title: Quantitative detection of macular microvascular abnormalities identified by optical coherence tomography angiography in different hematological diseases
Authors: Tianzi Jian, Fabao Xu, Guihua Li, Li Zhang, Jung Peng
Year: 2024

Title: Nicotinamide enhances Treg differentiation by promoting Foxp3 acetylation in immune thrombocytopenia
Authors: Ju Li, Cheng Zhang, Yuefen Hu, Qi Feng, Xiang Hu
Year: 2024

Title: The effects of complement-independent, autoantibody-induced apoptosis of platelets in immune thrombocytopenia (ITP)
Authors: Lin Sun, Yichen Zhang, Ping Chen, Jung Peng, Zi Sheng
Year: 2024

Title: Post-transplant lymphoproliferative disorders after allogeneic hematopoietic stem cell transplantation: a case report, meta-analysis, and systematic review
Authors: You Yuan Su, Yafei Yu, Zhenyu Yan, Jung Peng, Xinguang Liu
Year: 2024

Title: Ion channel Piezo1 activation aggravates the endothelial dysfunction under a high glucose environment
Authors: Xiaoyu Zhang, Shaoqiu Leng, Xinyue Liu, Shuwen Wang, Jung Peng
Year: 2024

Title: Intelligent dual-modality label-free cell classification with light scattering imaging and Raman spectra measurements
Authors: Faihaa Mohammed Eltigani, Xiaoyu Zhang, Min Liu, Jung Peng, Xuantao Su
Year: 2024

Title: Eltrombopag plus diacerein vs eltrombopag in patients with ITP: a multicenter, randomized, open-label phase 2 trial
Authors: Lu Sun, Xiaoyang Huang, Juan Wang, Ming Hou, Yu Hou
Year: 2024

Title: Risk Factors for Mortality in Critically Ill Patients with Coagulation Abnormalities: A Retrospective Cohort Study
Authors: Qiuyu Guo, Jung Peng, Tichao Shan, Miao Xu
Year: 2024

Title: Platelet-derived TGF-β1 induces functional reprogramming of myeloid-derived suppressor cells in immune thrombocytopenia
Authors: Lingjun Wang, Haoyi Wang, Mingfang Zhu, Ming Hou, Yu Hou
Year: 2024

✅ Conclusion

Through his pioneering research, unwavering clinical dedication, and impactful academic leadership, Professor Jun Peng stands at the forefront of immuno-hematology. His work not only deepens scientific understanding of ITP but also contributes directly to improved patient outcomes. As he continues to inspire through teaching, research, and innovation, Professor Peng’s legacy is one of excellence, influence, and ongoing transformation in the global hematology community.

Burak Derkus | Cellular Neuroscience | Best Researcher Award

Posted on 19/04/2025 by Neuroscientists

Prof. Burak Derkus | Cellular Neuroscience | Best Researcher Award

Prof. Burak Derkus, Ankara University, Turkey.

Prof. Burak Derkus has distinguished himself as a pioneering academic and researcher at Ankara University, Turkey, where he has played a vital role in shaping the future of biomedical engineering. His work spans across key disciplines such as biosensors, nanobiotechnology, and lab-on-a-chip technologies. By merging biology with cutting-edge engineering, he has developed innovative solutions aimed at improving diagnostic efficiency and accessibility. His career reflects a balance between scientific discovery, practical application, and educational leadership.

Profile

Google Scholar

🎓 Early Academic Pursuits

From the heart of Turkey, Prof. Burak Derkus began his journey into the world of science and discovery with an unwavering curiosity and dedication. His early academic path was marked by a strong foundation in biomedical sciences, which he cultivated during his undergraduate and postgraduate studies. Prof. Derkus demonstrated exceptional aptitude in analytical thinking and laboratory precision, laying the groundwork for a promising academic future. His formative years were spent exploring the intersections of biology, materials science, and engineering, which later became the pillars of his specialized research focus.

🧪 Professional Endeavors

Prof. Derkus established himself as a dynamic figure in academia through his ongoing association with Ankara University, one of Turkey’s leading research institutions. Here, he contributed not only as a scholar but also as a mentor, actively participating in the development of innovative curriculum modules and engaging students in high-impact research. His professional path is characterized by his interdisciplinary approach, blending principles of nanotechnology, biomedical engineering, and microfabrication to tackle complex challenges in healthcare and diagnostics.

🔬 Contributions and Research Focus

Renowned for his pioneering work in lab-on-a-chip systems, biosensors, and nanobiotechnology, Prof. Derkus has carved out a unique niche in biomedical microdevices. His research focuses on developing miniaturized platforms that can detect diseases with higher sensitivity, speed, and accuracy. By integrating biomaterials with microfluidic technologies, he aims to revolutionize early disease diagnosis and personalized medicine. His published works are rich with innovation, often bridging the gap between engineering and clinical applications.

🏅 Accolades and Recognition

Over the years, Prof. Derkus has earned numerous accolades that reflect his scientific excellence and leadership. His publications in high-impact journals, along with international conference presentations, have positioned him as a thought leader in the biomedical engineering community. He has been invited to serve on editorial boards and scientific committees, further endorsing his reputation as a respected academic figure. These honors underscore his persistent efforts in advancing applied sciences and improving public health through technological innovation.

🌍 Impact and Influence

Prof. Derkus’s influence extends beyond Turkey, resonating across international scientific circles. His research projects have fostered collaborations with institutions across Europe and Asia, facilitating knowledge exchange and cross-border innovation. By mentoring graduate students and young researchers, he continues to inspire a new generation of scientists. His contributions to the development of cost-effective, portable diagnostic tools hold immense potential for global health, particularly in under-resourced communities.

📚 Legacy and Future Contributions

Prof. Derkus is not just a researcher but a visionary thinker. His legacy is being built upon the transformative technologies he develops, aimed at addressing the future needs of society. His ongoing work promises to enhance biomedical diagnostics, therapeutic monitoring, and point-of-care testing. Looking ahead, he is poised to lead larger interdisciplinary collaborations, potentially contributing to the design of smart diagnostic devices powered by artificial intelligence and integrated sensors.

Publication

Title: Supramolecular self-assembly to control structural and biological properties of multicomponent hydrogels
Authors: BO Okesola, Y Wu, B Derkus, S Gani, D Wu, D Knani, DK Smith, …
Year: 2019

Title: Fabrication of human hair keratin/jellyfish collagen/eggshell-derived hydroxyapatite osteoinductive biocomposite scaffolds for bone tissue engineering: From waste to …
Authors: YE Arslan, TS Arslan, B Derkus, E Emregul, KC Emregul
Year: 2017

Title: Applying the miniaturization technologies for biosensor design
Authors: B Derkus
Year: 2016

Title: Myelin basic protein immunosensor for multiple sclerosis detection based upon label-free electrochemical impedance spectroscopy
Authors: B Derkus, E Emregul, C Yucesan, KC Emregul
Year: 2013

Title: Simultaneous quantification of Myelin Basic Protein and Tau proteins in cerebrospinal fluid and serum of Multiple Sclerosis patients using nanoimmunosensor
Authors: B Derkus, PA Bozkurt, M Tulu, KC Emregul, C Yucesan, E Emregul
Year: 2017

Title: Growth‐Factor Free Multicomponent Nanocomposite Hydrogels That Stimulate Bone Formation
Authors: B Okesola, S Ni, B Derkus, C Galeano, A Hasan, Y Wu, J Ramis, L Buttery, …
Year: 2020

Title: Untargeted multi-omic analysis of colorectal cancer-specific exosomes reveals joint pathways of colorectal cancer in both clinical samples and cell culture
Authors: CC Eylem, M Yilmaz, B Derkus, E Nemutlu, CB Camci, E Yilmaz, …
Year: 2020

Title: Multicomponent hydrogels for the formation of vascularized bone-like constructs in vitro
Authors: B Derkus, BO Okesola, DW Barrett, M D’Este, TT Chowdhury, D Eglin, …
Year: 2020

🧭 Conclusion

Prof. Derkus’s journey is a testament to the power of interdisciplinary research and its potential to drive meaningful change in global healthcare. His contributions have not only advanced scientific knowledge but also inspired collaborative innovation on an international scale. With a forward-looking mindset and a deep commitment to societal benefit, he continues to influence the field through research, mentorship, and visionary thinking. As science and medicine evolve, Prof. Burak Derkus remains a guiding force, building a legacy rooted in healing, discovery, and human impact.

Ketan Bulsara | Cellular Neuroscience | Excellence in Neuroscience Research Award

Posted on 29/03/2025 by Neuroscientists

Dr. Ketan Bulsara | Cellular Neuroscience | Excellence in Neuroscience Research Award

Dr. Ketan Bulsara, University of Connecticut, United States.

Dr. Ketan Ramanlal Bulsara is a distinguished neurosurgeon, educator, and administrator whose career has been defined by excellence in academic leadership, innovative research, and patient-centered surgical advancements. With a strong foundation in medical education and training, he has held prestigious positions at leading institutions, making significant contributions to the fields of cerebrovascular and skull base surgery. His work in neurosurgical education, healthcare policy, and perioperative quality improvement continues to influence the next generation of medical professionals.

Profile

Google Scholar

🎓 Early Academic Pursuits: The Foundation of Excellence

Dr. Ketan Ramanlal Bulsara’s journey into the world of neurosurgery began with a strong academic foundation. He earned his Bachelor of Science in Biology and Neuroscience, graduating Magna Cum Laude from Davidson College in 1992. His passion for medicine led him to Duke University School of Medicine, where he earned his Medical Degree with Honors in 1996. Committed to mastering his craft, Dr. Bulsara underwent rigorous neurosurgical training at Duke University Medical Center, progressing through internship, residency, and chief residency roles. His dedication to specialized knowledge took him to the University of Iowa for a fellowship in Transoral Surgery and later to Duke’s Neurovascular Program for an advanced Endovascular Fellowship, earning CAST certification by the Senior Neurological Society.

🎉 Professional Endeavors: Pioneering Neurosurgical Excellence

Dr. Bulsara has held esteemed academic and leadership positions throughout his career. Beginning as an Assistant Professor at the University of Missouri, he quickly ascended to directorship roles at Yale University, where he led Neuroendovascular and Skull Base Surgery Programs. His expertise and leadership took him to UConn Health, where he has served as Professor and Chief of Neurosurgery since 2017. As Program Director of UConn’s Neurosurgery Residency Training Program and Director of Operating Room Quality, he has been instrumental in shaping the next generation of neurosurgeons. His administrative impact extended further when he was appointed Interim Inaugural Chairman of UConn’s Department of Neurosurgery in 2024.

📚 Contributions and Research Focus: Advancing Neurosurgical Innovation

Throughout his career, Dr. Bulsara has been at the forefront of neurosurgical research, focusing on cerebrovascular and skull base surgery, neuroendovascular techniques, and perioperative advancements. His tenure at Yale and UConn Health has been marked by groundbreaking contributions to neurosurgical methodologies, patient safety protocols, and cutting-edge surgical interventions. With a keen interest in medical policy and administration, he also serves as Chair of the UConn Health/University of Connecticut Dean’s Task Force on Coding and Documentation, ensuring optimal standards in medical practice.

🏆 Accolades and Recognition: A Trailblazer’s Achievements

Dr. Bulsara’s exemplary work has earned him widespread recognition in academic, clinical, and administrative spheres. His leadership has been pivotal in strengthening neurosurgical departments and residency programs, earning respect from peers and students alike. His continued commitment to excellence led him to pursue an Executive MBA at Yale School of Management, which he completed in 2017, equipping him with advanced skills in healthcare management and strategic planning. Furthering his multidisciplinary expertise, he embarked on a legal education at the University of Connecticut School of Law in 2024, highlighting his commitment to integrating medicine, business, and law for the betterment of healthcare.

💡 Impact and Influence: Shaping the Future of Neurosurgery

Dr. Bulsara’s influence extends far beyond the operating room. As a mentor, he has trained and guided numerous neurosurgeons, instilling in them the values of precision, innovation, and patient-centered care. His research and administrative contributions have shaped hospital policies and perioperative strategies, leading to improved surgical outcomes and enhanced healthcare delivery systems. His work in academic leadership continues to bridge the gap between medical practice, research, and education.

Publication

Spinal axon regeneration evoked by replacing two growth cone proteins in adult neurons – HM Bomze, KR Bulsara, BJ Iskandar, P Caroni, JH Pate Skene (2001)

Longitudinal molecular trajectories of diffuse glioma in adults – FP Barthel, KC Johnson, FS Varn, AD Moskalik, G Tanner, E Kocakavuk, et al. (2019)

Glioma progression is shaped by genetic evolution and microenvironment interactions – FS Varn, KC Johnson, J Martinek, JT Huse, MLP Nasrallah, P Wesseling, et al. (2022)

Accuracy of prediction instruments for diagnosing large vessel occlusion in individuals with suspected stroke: a systematic review for the 2018 guidelines for the early… – EE Smith, DM Kent, KR Bulsara, LY Leung, JH Lichtman, MJ Reeves, et al. (2018)

Perioperative complications in transforaminal lumbar interbody fusion versus anterior–posterior reconstruction for lumbar disc degeneration and instability – AT Villavicencio, S Burneikiene, KR Bulsara, JJ Thramann (2006)

Vessel wall magnetic resonance imaging identifies the site of rupture in patients with multiple intracranial aneurysms: proof of principle – CC Matouk, DM Mandell, M Günel, KR Bulsara, A Malhotra, R Hebert, et al. (2013)

Safety of transforaminal lumbar interbody fusion and intervertebral recombinant human bone morphogenetic protein—2 – AT Villavicencio, S Burneikiene, EL Nelson, KR Bulsara, M Favors, et al. (2005)

Laminectomy versus percutaneous electrode placement for spinal cord stimulation – AT Villavicencio, JC Leveque, L Rubin, K Bulsara, JP Gorecki (2000)

Indications for thrombectomy in acute ischemic stroke from emergent large vessel occlusion (ELVO): report of the SNIS Standards and Guidelines Committee – M Mokin, SA Ansari, RA McTaggart, KR Bulsara, M Goyal, M Chen, et al. (2019)

Review of the literature on de novo formation of cavernous malformations of the central nervous system after radiation therapy – SM Nimjee, CJ Powers, KR Bulsara (2006)

💪 Conclusion

A visionary in neurosurgery, Dr. Bulsara’s impact transcends surgical practice, reaching into medical education, research, and healthcare administration. His multidisciplinary approach—combining medicine, business, and law—positions him as a leader in shaping the future of healthcare. His commitment to innovation and excellence ensures that his contributions will continue to elevate neurosurgical standards and inspire future generations of medical professionals.

Daša Zupančič | Cellular Neuroscience | Best Researcher Award

Posted on 29/03/2025 by Neuroscientists

Assoc. Prof. Dr. Daša Zupančič | Cellular Neuroscience | Best Researcher Award

Assoc. Prof. Dr. Daša Zupančič, Faculty of Medicine, University of Ljubljana, Slovenia.

Daša Zupančič is a distinguished academic and researcher specializing in cell biology, urothelial pathology, and medical education. Her extensive contributions to scientific research, particularly in the field of urothelial repair and cancer transformation, have earned her recognition, including the EMBO award. She has played a crucial role in mentoring and teaching, guiding future generations of researchers and medical professionals.

Profile

Orcid

✨ Early Academic Pursuits ✨

Daša Zupančič embarked on her academic journey with an unwavering passion for cell biology and medicine. She earned her Master’s degree in 2002 from the University of Ljubljana, Faculty of Medicine, where she meticulously explored cellular and molecular biological changes in the rat bladder urothelium following cyclophosphamide exposure. This formative research laid the foundation for her Ph.D., which she successfully completed in 2006, investigating the protective role of melatonin in urothelial injury and repair. Her dedication to advancing biomedical knowledge was evident from the very beginning of her scholarly career.

🎓 Professional Endeavors 🎓

Since 2006, Daša Zupančič has been an esteemed Associate Professor at the University of Ljubljana, Faculty of Medicine, Institute of Cell Biology. Prior to this, she gained valuable experience as a Young Researcher and Teaching Assistant from 1999 to 2006. Her extensive expertise and commitment to education have made her an integral part of the institution, where she continuously fosters scientific curiosity and excellence among students and colleagues alike.

🎡 Contributions and Research Focus 🎡

Throughout her career, Daša Zupančič has dedicated her research to understanding cellular mechanisms in urothelial biology and pathology. Her investigations into cyclophosphamide-induced urothelial injury, melatonin’s protective effects, and retinoid signaling pathways in urothelial cancer transformation have provided valuable insights into cellular repair processes. Her work extends beyond laboratory research, influencing the medical community’s approach to urothelial diseases and potential therapeutic advancements.

🏆 Accolades and Recognition 🏆

Her exceptional contributions to biomedical research have been recognized on multiple platforms. In 2017, she was honored with the prestigious EMBO award for her short-term scholarship project on the role of the retinoid signaling pathway in urothelial cancer transformation. This recognition underscores her significant impact on the scientific community and highlights her pioneering approach to understanding cancer pathophysiology.

👨‍🎓 Impact and Influence 👨‍🎓

A dedicated mentor, Daša Zupančič has guided numerous students towards academic excellence. Between 2014 and 2025, she has successfully mentored four master’s students and is currently supervising two more. In addition, she has overseen the research endeavors of four Ph.D. candidates, with one having successfully defended their dissertation in 2023 and another expected to graduate in 2025. Her mentorship has shaped the next generation of biomedical researchers, fostering a culture of rigorous inquiry and scientific discovery.

📚 Legacy and Future Contributions 📚

Beyond her research, Daša Zupančič plays a pivotal role in academia through her extensive teaching engagements. Since 2000, she has been a cornerstone of education at the University of Ljubljana, contributing to multiple faculties, including Medicine, Biotechnical Sciences, Health Sciences, and Pharmacy. She teaches a range of graduate and doctoral courses, covering essential subjects such as Medical Cell Biology, Immunology, and Research in Medicine. Her dedication to education ensures that her knowledge and expertise continue to shape the minds of aspiring medical professionals and researchers for years to come.

Publication

Vitamin A‐Enriched Diet Increases Urothelial Cell Proliferation by Upregulating Itga3 and Areg After Cyclophosphamide‐Induced Injury in Mice
Authors: Brina Dragar, Simona Kranjc Brezar, Maja Čemažar, Tanja Jesenko, Rok Romih, Mateja Erdani Kreft, Tadeja Kuret, Daša Zupančič
Year: 2025

Selective Targeting of Lectins and Their Macropinocytosis in Urothelial Tumours: Translation from in vitro to ex vivo
Authors: Nataša Resnik, Tanja Višnjar, Tomaž Smrkolj, Mateja Erdani Kreft, Rok Romih, Daša Zupančič
Year: 2023

Nanodiamonds as Possible Tools for Improved Management of Bladder Cancer and Bacterial Cystitis
Authors: Daša Zupančič, Peter Veranič
Year: 2022

Transmission Electron Microscopy Demonstration of Reduced Endothelial Glycocalyx in Severe Preeclampsia
Authors: Mugerli S, Zupančič D, Rok Romih, Lučovnik M
Year: 2022

Vitamin A and Retinoids in Bladder Cancer Chemoprevention and Treatment: A Narrative Review of Current Evidence, Challenges and Future Prospects
Authors: Larisa Tratnjek, Jera Jeruc, Rok Romih, Daša Zupančič
Year: 2021

Immunohistochemistry as a Paramount Tool in Research of Normal Urothelium, Bladder Cancer and Bladder Pain Syndrome
Authors: Daša Zupančič, Rok Romih
Year: 2021

Combined Lectin- and Immuno-Histochemistry (CLIH) for Applications in Cell Biology and Cancer Diagnosis: Analysis of Human Urothelial Carcinomas
Authors: Daša Zupančič
Year: 2020

Vitamin A Rich Diet Diminishes Early Urothelial Carcinogenesis by Altering Retinoic Acid Signaling
Authors: Daša Zupančič, Jelena Korać-Prlić, Mateja Erdani Kreft, Lucija Franković, Katarina Vilović, Jera Jeruc, Rok Romih, Janoš Terzić
Year: 2020

Lectins as Possible Tools for Improved Urinary Bladder Cancer Management
Authors: Daša Zupančič
Year: 2019

Co-Culturing Porcine Normal Urothelial Cells, Urinary Bladder Fibroblasts and Smooth Muscle Cells for Tissue Engineering Research
Authors: Daša Zupančič
Year: 2018

🌟 Conclusion 🌟

With a career dedicated to pioneering research, impactful mentorship, and transformative education, Daša Zupančič continues to leave a lasting legacy in the scientific and academic communities. Her work not only enhances understanding of urothelial biology but also inspires innovation and discovery among young scientists. As she continues her academic and research endeavors, her influence on the field will undoubtedly grow, shaping the future of biomedical sciences.